Clearance of Pneumocystis carinii in mice is dependent on B cells but not on P carinii-specific antibody

J Immunol. 2003 Aug 1;171(3):1423-30. doi: 10.4049/jimmunol.171.3.1423.

Abstract

Both CD4(+) T cells and B cells are critical for defense against Pneumocystis carinii infection; however, the mechanism by which B cells mediate protection is unknown. We show that P. carinii-specific IgM is not sufficient to mediate clearance of P. carinii from the lungs since CD40-deficient mice produced normal levels of specific IgM, but were unable to clear the organisms. Using chimeric mice in which the B cells were deficient in CD40 (CD40KO chimeras) we found that clearance of P. carinii infection is delayed compared with wild-type controls. These CD40KO chimeric mice produced normal levels of P. carinii-specific IgM, but did not produce class-switched IgG or IgA. Similarly, clearance of P. carinii was delayed in mice deficient in FcgammaRI and III (FcgammaRKO), indicating that P. carinii-specific IgG partially mediates opsonization and clearance of P. carinii. Opsonization of organisms by complement did not compensate for the lack of specific IgG or FcgammaR, since C3-deficient and C3-depleted FcgammaRKO mice were still able to clear P. carinii. Finally, micro MT and CD40KO chimeric mice had reduced numbers of activated CD4(+) T cells in the lungs and lymph nodes compared with wild-type mice, suggesting that B cells are important for activation of T cells in response to P. carinii. Together these data indicate that P. carinii-specific IgG plays an important, but not critical, role in defense against P. carinii. Moreover, these data suggest that B cells also mediate host defense against P. carinii by facilitating CD4(+) T cell activation or expansion.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antibodies, Fungal / physiology*
  • Antibody Specificity*
  • B-Lymphocyte Subsets / immunology*
  • B-Lymphocyte Subsets / metabolism
  • B-Lymphocyte Subsets / pathology
  • Bronchi
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / pathology
  • CD40 Antigens / genetics
  • CD40 Antigens / metabolism
  • CD40 Antigens / physiology
  • CD40 Ligand / metabolism
  • CD40 Ligand / physiology
  • Chimera / genetics
  • Chimera / immunology
  • Complement System Proteins / deficiency
  • Complement System Proteins / genetics
  • Down-Regulation / genetics
  • Down-Regulation / immunology
  • Immunologic Deficiency Syndromes / genetics
  • Immunologic Deficiency Syndromes / immunology
  • Immunologic Deficiency Syndromes / microbiology
  • Immunologic Deficiency Syndromes / pathology
  • Lung / immunology
  • Lung / pathology
  • Lymph Nodes / immunology
  • Lymph Nodes / pathology
  • Lymphocyte Activation / genetics
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, SCID
  • Pneumocystis / growth & development*
  • Pneumocystis / immunology*
  • Pneumonia, Pneumocystis / genetics
  • Pneumonia, Pneumocystis / immunology
  • Pneumonia, Pneumocystis / microbiology*
  • Pneumonia, Pneumocystis / prevention & control*
  • Receptors, IgG / deficiency
  • Receptors, IgG / genetics
  • Trachea

Substances

  • Antibodies, Fungal
  • CD40 Antigens
  • Receptors, IgG
  • CD40 Ligand
  • Complement System Proteins